These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1388697)

  • 21. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
    Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
    Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
    Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
    Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
    Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat.
    Cenci MA; Kalén P; Mandel RJ; Björklund A
    Brain Res; 1992 May; 581(2):217-28. PubMed ID: 1393530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains.
    Sivam SP
    Neuropeptides; 1991 Apr; 18(4):201-7. PubMed ID: 1711165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.
    Mogi M; Togari A; Kondo T; Mizuno Y; Komure O; Kuno S; Ichinose H; Nagatsu T
    Neurosci Lett; 1999 Jul; 270(1):45-8. PubMed ID: 10454142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical aspects of Parkinson's disease.
    Hornykiewicz O
    Neurology; 1998 Aug; 51(2 Suppl 2):S2-9. PubMed ID: 9711973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.
    Fernandez A; de Ceballos ML; Rose S; Jenner P; Marsden CD
    Brain; 1996 Jun; 119 ( Pt 3)():823-30. PubMed ID: 8673494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG
    Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.
    Ge J; Barnes NM
    Eur J Pharmacol; 1996 Feb; 297(3):299-306. PubMed ID: 8666063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
    Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An HPLC-ECD procedure for measuring total phenolsulfotransferase (PST) activity in human liver, platelets and blood.
    Khoo BY; Sit KH; Wong KP
    Clin Chim Acta; 1990 Dec; 194(2-3):219-28. PubMed ID: 2093474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.